Table 1.
HCV Pathway | Usual Care | p-Value | ||
---|---|---|---|---|
Total 2015–2018 | Patient | 131,176 (100.0%) | 128,311 (100.0%) | |
Age group | 18–19 | 1145 (0.9%) | 3987 (3.1%) | <0.001 |
20–29 | 10,804 (8.2%) | 34,088 (26.6%) | <0.001 | |
30–39 | 9862 (7.5%) | 27,794 (21.7%) | <0.001 | |
40–49 | 8550 (6.5%) | 19,107 (14.9%) | <0.001 | |
50–59 | 50,164 (38.2%) | 22,030 (17.2%) | <0.001 | |
60–69 | 43,926 (33.5%) | 16,663 (13.0%) | <0.001 | |
70–79 | 6481 (4.9%) | 3907 (3.0%) | <0.001 | |
80–89 | 232 (0.2%) | 693 (0.5%) | <0.001 | |
90–99 | 12 (0.0%) | 41 (0.0%) | <0.001 | |
100+ | 0 | 1 (0.0%) | 0.312 | |
Baby boomer | Baby boomer | 98,331 (75.0%) | 39,134 (30.5%) | <0.001 |
Not baby boomer | 32,845 (25.0%) | 89,177 (69.5%) | <0.001 | |
Sex | Female | 71,593 (54.6%) | 86,575 (67.5%) | <0.001 |
Male | 59,583 (45.4%) | 41,736 (32.5%) | <0.001 | |
Pregnancy | Pregnancy during testing | 403 (0.6%) | 3459 (4.0%) | <0.001 |
Race | American Indian/Alaskan native | 714 (0.5%) | 764 (0.6%) | 0.084 |
Asian | 18,813 (14.3%) | 15,950 (12.4%) | <0.001 | |
Black/African American | 54,201 (41.3%) | 58,420 (45.5%) | <0.001 | |
Native Hawaiian/ Pacific islander | 388 (0.3%) | 346 (0.3%) | 0.21 | |
Unknown or not reported | 17,022 (13.0%) | 18,316 (14.3%) | <0.001 | |
White/ Caucasian | 39,111 (29.8%) | 33,167 (25.8%) | <0.001 | |
Other | 927 (0.7%) | 1348 (1.1%) | <0.001 | |
Insurance | Commercial | 96,326 (73.4%) | 103,012 (80.3%) | <0.001 |
Medicaid | 9131 (7.0%) | 11,356 (8.9%) | <0.001 | |
Medicare | 24,790 (18.9%) | 12,459 (9.7%) | <0.001 | |
Other | 64 (0.0%) | 120 (0.1%) | <0.001 | |
Unknown | 865 (0.7%) | 1364 (1.1%) | <0.001 | |
IV drug use | No or unknown | 131,087 (99.9%) | 128,291 (100%) | <0.001 |
Yes | 89 (0.1%) | 20 (0.0%) | <0.001 | |
Sexual history: men who have sex with men (MSM) | No or unknown | 128,481 (97.9%) | 125,040 (97.5%) | <0.001 |
Yes | 2695 (2.1%) | 3271 (2.5%) | <0.001 |